FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2140281860> ?p ?o ?g. }

• W2140281860 endingPage "1491" @default.
• W2140281860 startingPage "1481" @default.
• W2140281860 abstract "Objective: To conduct an economic evaluation of terlipressin, octreotide and placebo in the treatment of bleeding oesophageal varices (BOV) where endotherapy could be used concomitantly.Methods: A discrete event simulation model was created with transition states: bleeding, no bleeding, no bleeding post transjugular intrahepatic portosystemic shunt, post-salvage surgery, and death. Efficacy data on survival, re-bleeding and control of bleeding were obtained from high quality studies reported in Cochrane meta-analyses. Baseline outcomes related to the course of disease and health-state utilities were derived from published sources. Vasoactive treatment costs and all related BOV costs were obtained from published UK sources.Results: The average aggregated treatment cost per person for all medical interventions at 1 year was lower for terlipressin-treated patients (£2623) compared with those treated using octreotide (£2758) or placebo (£2890). The incremental analysis comparing terlipressin with octreotide and placebo using a cost per quality adjusted life year (QALY) and cost per life year gained (LYG) approach indicated that terlipressin was the dominant BOV treatment option (i.e. it cost less and it was more effective). Based on a maximum willingness to pay of £20 000/QALY terlipressin was more effective and cost-saving compared to octreotide and placebo for simulations ranging from 42 days to 2 years. In point estimation analyses octreotide was dominant compared to placebo; however, probabilistic sensitivity analysis indicated that octreotide was unlikely to be cost-effective compared to placebo.Conclusions: The findings indicated that vasoactive treatment in BOV was cost-savingcompared to no vasoactive treatment. Furthermore, terlipressin was the more cost-effective vasoactive treatment for BOV in cirrhotic patients." @default.
• W2140281860 created "2016-06-24" @default.
• W2140281860 creator A5013289197 @default.
• W2140281860 creator A5023835730 @default.
• W2140281860 creator A5053437261 @default.
• W2140281860 creator A5073613780 @default.
• W2140281860 creator A5074572540 @default.
• W2140281860 creator A5077893105 @default.
• W2140281860 creator A5082958190 @default.
• W2140281860 creator A5082993583 @default.
• W2140281860 date "2007-05-23" @default.
• W2140281860 modified "2023-10-17" @default.
• W2140281860 title "An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis" @default.
• W2140281860 cites W1540607895 @default.
• W2140281860 cites W1965023728 @default.
• W2140281860 cites W1968123318 @default.
• W2140281860 cites W1973337979 @default.
• W2140281860 cites W1978824947 @default.
• W2140281860 cites W1981569008 @default.
• W2140281860 cites W1984597737 @default.
• W2140281860 cites W1996152976 @default.
• W2140281860 cites W1997229215 @default.
• W2140281860 cites W2029773978 @default.
• W2140281860 cites W2035317896 @default.
• W2140281860 cites W2040444046 @default.
• W2140281860 cites W2040538155 @default.
• W2140281860 cites W2047317121 @default.
• W2140281860 cites W2048457974 @default.
• W2140281860 cites W2052919939 @default.
• W2140281860 cites W2057856087 @default.
• W2140281860 cites W2085796730 @default.
• W2140281860 cites W2095095509 @default.
• W2140281860 cites W2108264364 @default.
• W2140281860 cites W2111820343 @default.
• W2140281860 cites W2131244623 @default.
• W2140281860 cites W2131903288 @default.
• W2140281860 cites W948457232 @default.
• W2140281860 doi "https://doi.org/10.1185/030079907x199736" @default.
• W2140281860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17559746" @default.
• W2140281860 hasPublicationYear "2007" @default.
• W2140281860 type Work @default.
• W2140281860 sameAs 2140281860 @default.
• W2140281860 citedByCount "13" @default.
• W2140281860 countsByYear W21402818602013 @default.
• W2140281860 countsByYear W21402818602014 @default.
• W2140281860 countsByYear W21402818602015 @default.
• W2140281860 countsByYear W21402818602019 @default.
• W2140281860 countsByYear W21402818602021 @default.
• W2140281860 countsByYear W21402818602023 @default.
• W2140281860 crossrefType "journal-article" @default.
• W2140281860 hasAuthorship W2140281860A5013289197 @default.
• W2140281860 hasAuthorship W2140281860A5023835730 @default.
• W2140281860 hasAuthorship W2140281860A5053437261 @default.
• W2140281860 hasAuthorship W2140281860A5073613780 @default.
• W2140281860 hasAuthorship W2140281860A5074572540 @default.
• W2140281860 hasAuthorship W2140281860A5077893105 @default.
• W2140281860 hasAuthorship W2140281860A5082958190 @default.
• W2140281860 hasAuthorship W2140281860A5082993583 @default.
• W2140281860 hasConcept C126322002 @default.
• W2140281860 hasConcept C141071460 @default.
• W2140281860 hasConcept C142724271 @default.
• W2140281860 hasConcept C204787440 @default.
• W2140281860 hasConcept C27081682 @default.
• W2140281860 hasConcept C2776297358 @default.
• W2140281860 hasConcept C2776988256 @default.
• W2140281860 hasConcept C2777214474 @default.
• W2140281860 hasConcept C2778012290 @default.
• W2140281860 hasConcept C2779393834 @default.
• W2140281860 hasConcept C2781025020 @default.
• W2140281860 hasConcept C42219234 @default.
• W2140281860 hasConcept C71924100 @default.
• W2140281860 hasConceptScore W2140281860C126322002 @default.
• W2140281860 hasConceptScore W2140281860C141071460 @default.
• W2140281860 hasConceptScore W2140281860C142724271 @default.
• W2140281860 hasConceptScore W2140281860C204787440 @default.
• W2140281860 hasConceptScore W2140281860C27081682 @default.
• W2140281860 hasConceptScore W2140281860C2776297358 @default.
• W2140281860 hasConceptScore W2140281860C2776988256 @default.
• W2140281860 hasConceptScore W2140281860C2777214474 @default.
• W2140281860 hasConceptScore W2140281860C2778012290 @default.
• W2140281860 hasConceptScore W2140281860C2779393834 @default.
• W2140281860 hasConceptScore W2140281860C2781025020 @default.
• W2140281860 hasConceptScore W2140281860C42219234 @default.
• W2140281860 hasConceptScore W2140281860C71924100 @default.
• W2140281860 hasIssue "7" @default.
• W2140281860 hasLocation W21402818601 @default.
• W2140281860 hasLocation W21402818602 @default.
• W2140281860 hasOpenAccess W2140281860 @default.
• W2140281860 hasPrimaryLocation W21402818601 @default.
• W2140281860 hasRelatedWork W1963531850 @default.
• W2140281860 hasRelatedWork W1999204372 @default.
• W2140281860 hasRelatedWork W2049721171 @default.
• W2140281860 hasRelatedWork W2083465908 @default.
• W2140281860 hasRelatedWork W2108091943 @default.
• W2140281860 hasRelatedWork W2111870210 @default.
• W2140281860 hasRelatedWork W2154362091 @default.
• W2140281860 hasRelatedWork W2387197710 @default.
• W2140281860 hasRelatedWork W4298075733 @default.

• next